Overview |
bsm-54756R |
LPP Monoclonal Antibody |
WB |
Human |
Specifications |
Unconjugated |
Rabbit |
Synthetic peptide within N-terminal Human LPP. |
Monoclonal |
2H15 |
IgG |
1ug/ul |
Purified by Protein A. |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Store at -20°C for 12 months. |
Target |
4026 |
Q93052 |
Cytoplasm, Nucleus, Cell membrane, Cell junction |
DKFZp779O0231 antibody, FLJ30652 antibody, FLJ41512 antibody, LIM domain containing preferred translocation partner in lipoma antibody, LIM domain-containing preferred translocation partner in lipoma antibody, LIM protein antibody, Lipoma preferred partner antibody, Lipoma-preferred partner antibody, lpp antibody, LPP_HUMAN antibody |
LPP (LIM containing lipoma preferred partner), is a scaffolding protein which contains three LIM domains at its carboxy terminus, preceded by a proline rich pre LIM region containing a number of protein interaction domains. LPP localizes to sites of cell adhesion, such as focal adhesions and cell-cell contacts and may be involved in cell-cell adhesion and cell motility. LPP also shuttles through the nucleus and may function as a transcriptional co-activator. The human LPP gene maps to chromosomal location 3q28, and preferentially translocates to the HMGIC gene in a subclass of human benign mesenchymal tumors known as lipomas. Alternate splicing results in multiple transcript variants. |
Application Dilution |
WB |
1:300-5000 |